Karen Cornelissen

Karen Cornelissen has work experience as the Director of Early Clinical Development at F2G since February 2017. Prior to that, they worked at Covance as a Scientific Director since 1999.

Karen Cornelissen has a Bachelor of Science (BSc) degree in Pharmacology from Portsmouth Polytechnic. Karen also pursued further education in the field of Drug Metabolism and obtained a Doctor of Philosophy (PhD) degree from the University of Bath.